Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia

被引:286
作者
Biolo, Gianni [1 ]
Cederholm, Tommy [2 ]
Muscaritoli, Maurizio [3 ]
机构
[1] Univ Trieste, AOUTS, Dept Med Surg & Hlth Sci Clin Med, I-34127 Trieste, Italy
[2] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
[3] Univ Roma La Sapienza, Dept Clin Med, I-00185 Rome, Italy
关键词
Sarcopenia; Cachexia; Sarcopenic obesity; Muscle metabolic dysfunction; Pre-cachexia; Muscle contractile dysfunction; RESTING ENERGY-EXPENDITURE; BODY-MASS INDEX; CHRONIC HEART-FAILURE; SKELETAL-MUSCLE; BED-REST; INSULIN-RESISTANCE; CANCER-PATIENTS; PROTEIN-METABOLISM; AMINO-ACID; NEOADJUVANT CHEMOTHERAPY;
D O I
10.1016/j.clnu.2014.03.007
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Skeletal muscle is the most abundant body tissue accounting for many physiological functions. However, muscle mass and functions are not routinely assessed. Sarcopenia is defined as skeletal muscle loss and dysfunction in aging and chronic diseases. Inactivity, inflammation, age-related factors, anorexia and unbalanced nutrition affect changes in skeletal muscle. Mechanisms are difficult to distinguish in individual subjects due to the multifactorial character of the condition. Sarcopenia includes both muscle loss and dysfunction which induce contractile impairment and metabolic and endocrine abnormalities, affecting whole-body metabolism and immune/inflammatory response. There are different metabolic trajectories for muscle loss versus fat changes in aging and chronic diseases. Appetite regulation and physical activity affect energy balance and changes in body fat mass. Appetite regulation by inflammatory mediators is poorly understood. In some patients, inflammation induces anorexia and fat loss in combination with sarcopenia. In others, appetite is maintained, despite activation of systemic inflammation, leading to sarcopenia with normal or increased BMI. Inactivity contributes to sarcopenia and increased fat tissue in aging and diseases. At the end of the metabolic trajectories, cachexia and sarcopenic obesity are paradigms of the two patient categories. Pre-cachexia and cachexia are observed in patients with cancer, chronic heart failure or liver cirrhosis. Sarcopenic obesity and sarcopenia with normal/increased BMI are observed in rheumatoid arthritis, breast cancer patients with adjuvant chemotherapy and in most of patients with COPD or chronic kidney disease. In these conditions, sarcopenia is a powerful prognostic factor for morbidity and mortality, independent of BMI. (C) 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:737 / 748
页数:12
相关论文
共 145 条
  • [1] Agostini F, 2005, J PHYSL, V586, P4775
  • [2] Effects of inactivity on human muscle glutathione synthesis by a double-tracer and single-biopsy approach
    Agostini, Francesco
    Dalla Libera, Luciano
    Rittweger, Joern
    Mazzucco, Sara
    Jurdana, Mihaela
    Mekjavic, Igor B.
    Pisot, Rado
    Gorza, Luisa
    Narici, Marco
    Biolo, Gianni
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2010, 588 (24): : 5089 - 5104
  • [3] Effect of obesity on intensive care morbidity and mortality: A meta-analysis
    Akinnusi, Morohunfolu E.
    Pineda, Lilibeth A.
    El Solh, Ali A.
    [J]. CRITICAL CARE MEDICINE, 2008, 36 (01) : 151 - 158
  • [4] PGC-1α and Myokines in the Aging Muscle - A Mini-Review
    Arnold, Anne-Sophie
    Egger, Anna
    Handschin, Christoph
    [J]. GERONTOLOGY, 2011, 57 (01) : 37 - 43
  • [5] Effects of Muscular Strength on Cardiovascular Risk Factors and Prognosis
    Artero, Enrique G.
    Lee, Duck-chul
    Lavie, Carl J.
    Espana-Romero, Vanesa
    Sui, Xuemei
    Church, Timothy S.
    Blair, Steven N.
    [J]. JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2012, 32 (06) : 351 - 358
  • [6] Changes in Myostatin Signaling in Non-Weight-Losing Cancer Patients
    Aversa, Zaira
    Bonetto, Andrea
    Penna, Fabio
    Costelli, Paola
    Di Rienzo, Gaetano
    Lacitignola, Angelo
    Baccino, Francesco M.
    Ziparo, Vincenzo
    Mercantini, Paolo
    Rossi Fanelli, Filippo
    Muscaritoli, Maurizio
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (04) : 1350 - 1356
  • [7] Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
    Awad, Sherif
    Tan, Benjamin H.
    Cui, Helen
    Bhalla, Ashish
    Fearon, Kenneth C. H.
    Parsons, Simon L.
    Caton, James A.
    Lobo, Dileep N.
    [J]. CLINICAL NUTRITION, 2012, 31 (01) : 74 - 77
  • [8] Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
    Baracos, Vickie E.
    Reiman, Tony
    Mourtzakis, Marina
    Gioulbasanis, Ioannis
    Antoun, Sami
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (04) : 1133S - 1137S
  • [9] Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group
    Bauer, Juergen
    Biolo, Gianni
    Cederholm, Tommy
    Cesari, Matteo
    Cruz-Jentoft, Alfonso J.
    Morley, John E.
    Phillips, Stuart
    Sieber, Cornel
    Stehle, Peter
    Teta, Daniel
    Visvanathan, Renuka
    Volpi, Elena
    Boirie, Yves
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2013, 14 (08) : 542 - 559
  • [10] What's in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?"
    Binkley, N.
    Krueger, D.
    Buehring, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 (12) : 2955 - 2959